GGD Amsterdam participates in research into new hiv-preventiepil
Photo: Hollandse Hoogte
The municipal health service in Amsterdam participates in international scientific research into a new hiv-preventiepil. It should show that the experimental medicine F/TAF is safe and effective for the prevention of hiv infection in healthy adults.
Interested gay men and transgender women who have sex with men may to 26 march sign, made to the health service Friday known.
The new PrEP pill (a pill with antiretrovirals to hiv to prevent infection) according to the pharmaceutical company Gilead Sciences have fewer side effects such as renal impairment or bone density loss than the current means. PrEP is intended for people who are not hiv-infected but at increased risk.
In total about five thousand subjects participate in approximately one hundred centres in North America and Europe.
In response, says Dutch aids foundation distressing to find that people have to opt for participation in a study to provide access to PrEP. “Dutch aids foundation wants everyone with a increased risk to get access to a deterrent of which we know for sure that it works and is affordable”, says Louise van Deth, director of Aidsfons-Soa Aids Nederland.
“It is unacceptable that the existing and proven effective PrEP pill still not accessible and affordable in the Netherlands. PrEP prevents hiv, saves costs and frees people from fear of hiv.”